Shide K, Kameda T, Kamiunten A, Ozono Y, Tahira Y, Yokomizo-Nakano T, Kubota S, Ono M, Ikeda K, Sekine M, Akizuki K, Nakamura K, Hidaka T, Kubuki Y, Iwakiri H, Hasuike S, Nagata K, Sashida G, Shimoda K. Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms in mice. Blood. 202007; 136(1):106-118.
Kikuchi T, Mimura K, Ashizawa M, Okayama H, Endo E, Saito K, Sakamoto W, Fujita S, Endo H, Saito M, Momma T, Saze Z, Ohki S, Shimada K, Yoshimura K, Tsunoda T, Kono K. Characterization of tumorinfiltrating immune cells in relation to microbiota in colorectal cancers. Cancer Immunology, Immunotherpy. 202001; 69(1):23-32.
Ujiie D, Okayama H, Saito K, Ashizawa M, Thar Min AK, Endo E, Kase K, Yamada L, Kikuchi T, Hanayama H, Fujita S, Sakamoto W, Endo H, Saito M, Mimura K, Saze Z, Momma T, Ohki S, Kono K. KRT17 as a prognostic biomarker for stage II colorectal cancer. Carcinogenesis. 202007; 41(5):591-599.
Go H, Ohto H, Nollet KE, Takano S, Kashiwabara N, Chisiki M, Maeda H, Imamura T, Kawasaki Y, Momoi N, Hosoya M. Using Platelet Parameters to Anticipate Morbidity and Mortality Among Preterm Neonates:A Retrospective Study. Frontiers in Pediatrics. 202003; 8:90.
Kono K, Nakajima S, Mimura K. Current status of immune checkpoint inhibitors for gastric cancer. Gastric Cancer. 202007; 23(4):565-578.
Nakayama Y, Mimura K, Kua LF, Okayama H, Min AKT, Saito K, Hanayama H, Watanabe Y, Saito M, Momma T, Saze Z, Ohki S, Suzuki Y, Ichikawa D, Yong WP, Kono K. Immune suppression caused by PD-L2 expression on tumor cells in gastric cancer. Gastric Cancer. 202011; 23(6):961-973.
Watanabe M, Ohto H, Tormey CA, Yasuda H, Takano N, Minakawa K, Ono S, Yamada-Abe M, Suzuki H, Sugawara A, Kawabata K, Nollet KE, Ikeda K. Immunogenicity of red cell alloantigens in the Japanese population. International Journal of Blood transfusion and Immunohematology. 202010; 10(2):100053Z02MW2020.
Fujiwara SI, Ikeda K, Kino S, Tanaka A, Hasegawa Y, Fujino K, Makino S, Matsumoto M, Yokohama A, Takeshita A, Muroi K. Clinical significance of autologous blood transfusions in bone marrow harvest from unrelated donors. International Journal of Hematology. 202006; 111(6):833-839.
Yokohama A, Okuyama Y, Ueda Y, Itoh M, Fujiwara SI, Hasegawa Y, Nagai K, Arakawa K, Miyazaki K, Makita M, Watanabe M, Ikeda K, Tanaka A, Fujino K, Matsumoto M, Makino S, Kino S, Takeshita A, Muroi K. Differences among hemoglobin thresholds for red blood cell transfusions in patients with hematological diseases in teaching hospitals: a real world data in Japan. International Journal of Hematology. 202010; 112(4):535-543.
Matsumoto T, Okayama H, Nakajima S, Saito K, Nakano H, Endo E, Kase K, Ito M, Yamauchi N, Yamada L, Kanke Y, Onozawa H, Fujita S, Sakamoto W, Saito M, Saze Z, Momma T, Mimura K, Kono K. Tn Antigen Expression Defines an Immune Cold Subset of Mismatch-Repair Deficient Colorectal Cancer. International Journal of Molecular Sciences. 202011; 21(23):9081.
Go H, Ohto H, Nollet KE, Kashiwabara N, Ogasawara K, Chishiki M, Hiruta S, Sakuma I, Kawasaki Y, Hosoya M. Risk factors and treatments for disseminated intravascular coagulation in neonates. Italian Journal of Pediatrics. 202004; 46(1):54.
Sano H, Mochizuki K, Kobayashi S, Ono S, Ikeda K, Ohto H, Kikuta A. Two Occurrences of Leukemia Relapse Due to Mismatched HLA Loss After Haploidentical Stem Cell Transplantation From Different Family Donors With KIR Ligand Mismatch. Journal of Pediatric Hematology/Oncology. 202003; 42(2):e104-e106.
Kimura S, Imagawa J, Murai K, Hino M, Kitawaki T, Okada M, Tanaka H, Shindo M, Kumagai T, Ikezoe T, Uoshima N, Sato T, Watanabe R, Kowata S, Hayakawa M, Hosoki T, Ikeda K, Kobayashi T, Kakinoki Y, Nishimoto T, Takezako N, Shibayama H, Takaori-Kondo A, Nakamae H, Kawaguchi A, Ureshino H, Sakamoto J, Ishida Y. Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial. Lancet Haematology. 202003; 7(3):e218-e225.
Endo E, Okayama H, Saito K, Nakajima S, Yamada L, Ujiie D, Kase K, Fujita S, Endo H, Sakamoto W, Saito M, Saze Z, Momma T, Ohki S, Mimura K, Kono K. A TGFβ-dependent stromal subset underlies immune checkpoint inhibitor efficacy in DNA mismatch repair-deficient/microsatellite instability-high colorectal cancer. Molecular Cancer Research. 202009; 18(9):1402-1413.
Go H, Ohto H, Nollet KE, Kashiwabara N, Chisiki M, Hoshino M, Ogasawara K, Kawasaki Y, Momoi N, Hosoya M. Perinatal factors affecting platelet parameters in late preterm and term neonates. PLOS ONE. 202011; 15(11):e0242539.
Ikeda K, Ohto H, Yamada-Fujiwara M, Okuyama Y, Fujiwara SI, Muroi K, Mori T, Kasama K, Kanamori H, Iseki T, Nagamura-Inoue T, Kameda K, Kanda J, Nagai K, Fujii N, Ashida T, Hirose A, Takahashi T, Minakawa K, Tanosaki R. Hematopoietic cell infusion-related adverse events in pediatric/small recipients in a prospective/multicenter study. Transfusion. 202005; 60(5):1015-1023.
Ogasawara K, Ohto H, Takano N, Nollet K, Go H, Sato M, Momoi N, Hosoya M. Assessment of a downsized potassium adsorption filter designed to transfuse neonates. Transfusion. 202011; 60(11):2494-2499.
Kimura S, Ohkawara H, Minakawa K, Fukatsu M, Mori H, Takahashi H, Harada-Shirado K, Ohara Y, Takahashi N, Mochizuki K, Sano H, Nollet KE, Ogawa K, Ohto H, Kikuta A, Ikeda K, Ikezoe T. Optimal timing of apheresis for the efficient mobilization of peripheral blood progenitor cells recruited by high-dose granulocyte colony-stimulating factor in healthy donors. Transfusion and Apheresis Science. 202006; 59(3):102737.
Takeshita A, Watanabe H, Yamada C, Nadarajan VS, Permpikul P, Sinkitjasub A, Natalie CPH, Zhao S, Han KS, Kim DW, Suh JS, Kim HO, Kawabata K, Ishimaru K, Ohtomo N, Yamada N, Tomoda Y, Yurugi K, Ohto H. Erythrocyte Alloimmunity and Genetic Variance: Results from the Collaborative Study of Alloimmunity to Antigen Diversity in Asian Populations (All ADP). Transfusion and Apheresis Science. 202010; 59(5):102944.
Ohto H, Denomme GA, Ito S, Ishida A, Nollet KE, Yasuda H. Three non-classical mechanisms for anemic disease of the fetus and newborn, based on maternal anti-kell, anti-Ge3, anti-M, and anti-Jra cases. Transfuion and Apheresis Science. 202010; 59(5):102949.
Yamada C, Takeshita A, Ohto H, Ishimaru K, Kawabata K, Nomaguchi Y, Haraguchi Y, Abe M, Sobue K, Takenouchi H, Takadate J, Kamimura M, Katai A, Kasai D, Minami Y, Sugimoto T, Michino J, Nagai K, Kumagai M, Hasegawa Y, Ishizuka K, Ohtomo N, Yamada N, Muroi K, Matsushita T, Takahashi K. A Japanese multi-institutional collaborative study of antigen-positive red blood cell (RBC) transfusions in patients with corresponding RBC antibodies. Vox Sanguinis. 202007; 115(5):456-465.
Ueda K, Kumari R, Steidl U. Fueling clonal dominance through TRAFficking of NF-kB signaling. Nature Immunology. 202005; 21(5):489-490.
Ohto H. Extension of Homo Sapiens Adapting to Every Environment with Divergent Phenotypes: Blood Type Incompatible in Pregnancy as an Abaxial Phenomenon. Transufusion and Apheresis Science. 202010; 59(5):102943.
川畑絹代. 【輸血検査 苦手克服BOOK】（PART 04）新生児・乳児の輸血検査／母児不適合妊娠の輸血検査. Medical Technology. 202012; 48(13):1488-1501.
Ueda K, Kumari R, Schwenger E, Wheat JC, Bohorquez O, Narayanagari S, Taylor SJ, Carvajal LA,Pradhan K, Bartholdy B, Todorova TI, Goto H, Sun D, Chen J, Shan J, Song Y, Montagna C, Xiong S,Lozano G, Verma A, Steidl U. MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia switchmechanism. ISEH (International Society for Experimental Hematology) virtual scientific meeting; 20200819-21; Web.
Yokokawa T, Misaka T, Kimishima Y, Wada K, Minakawa K, Sugimoto K, Ishida T, Ikeda K, Takeishi Y.Hematopoietic JAK2V617F mutation exacerbates aortic aneurysm development. The 64th Annual ScientificMeeting of The Korean Society of Cardiology; 20201016-18; Web.
Yokokawa T, Misaka T, Kimishima Y, Wada K, Minakawa K, Sugimoto K, Ishida T, Ikeda K, Takeishi Y.－271－Crucial role of Jak2V617f-positive myeloproliferative neoplasm in the development of aortic aneurysm.American Heart Association Scientific Session 2020; 20201113-17; Web. Circulation. 142(Suppl 3):A12726.
Kimishima Y, Misaka T, Yokokawa T, Wada K, Ueda K, Sugimoto K, Minakawa K, Nakazato K, Ishida T,Oshima M, Koide S, Shide K, Shimoda K, Iwama A, Ikeda K, Takeishi Y. Clonal hematopoiesis withJAK2V617F promotes pulmonary hypertension through ALK1. American Heart Association Scientific Session2020; 20201113-17; Web. Circulation. 142(Suppl 3):A12873.
Wada K, Misaka T, Yokokawa T, Kimishima Y, Minakawa K, Kaneshiro T, Yoshihisa A, Ikeda K, Takeishi Y.Clinical significance of clonal hematopoiesis with JAK2V617F in patients with cardiovascular diseases.American Heart Association Scientific Session 2020; 20201113-17; Web. Circulation. 142(Suppl 3):A13080.
Ikeda K, Muroi K, Ikeda K, Iseki T, Okuyama Y, Omokawa S, Yamamoto K, Kanamori H, Matsuzaki K,Ohto H. CERTIFICATION OF “QUALIFIED APHERESIS NURSE” BY THE JAPAN SOCIETY OFTRANSFUSION MEDICINE AND CELL THERAPY; A SUMMARY OF 10-YEAR EXPERIENCE OFCERTIFICATION AND RENEWAL PROCESS. ISBT2020; 20201212-16; Web. Vox Sanguinis. 115(S1):85.
Fujiwara S, Kishino K, Kino S, Tanaka A, Hasegawa Y, Makino S, Matsushita T, Matsumoto M, YokohamaA, Ikeda K, Takeshita A, Muroi K. ASSESSMENT OF IRON SUPPLEMENTATION DURINGAUTOLOGOUS BLOOD DONATION IN HEALTHY BONE MARROW DONORS. ISBT2020; 20201212-16;Web. Vox Sanguinis. 115(S1):134.
Ikeda K, Takano N, Rikimaru S, Kawabata K, Ohto H. CLOTTING ACTIVITIES OF FRESH FROZENPLASMA THAWED BY A NEWLY DEVELOPED DRY-THAWING DEVICE. ISBT2020; 20201212-16; Web.Vox Sanguinis. 115(S1):151.
Kimishima Y, Misaka T, Yokokawa T, Wada K, Sugimoto K, Minakawa K, Nakazato K, Ishida T, Ikeda Y,Takeishi K. Clonal hematopoiesis with JAK2V617F promotes pulmonary hypertension through ALK1. 第4 回日本循環器学会基礎研究フォーラム; 20200926-27; Web.
Wada K, Misaka T, Yokokawa T, Kimishima Y, Minakawa K, Kaneshiro T, Yoshihisa A, Ikeda K, Takeishi Y.Clinical significance of clonal hematopoiesis with JAK2V617F in patients with cardiovascular disease. 第4 回日本循環器学会基礎研究フォーラム; 20200926-27; Web.
Yokokawa T, Misaka T, Kimishima Y, Wada K, Minagawa K, Sugimoto K, Ishida T, Ikeda K, Takeishi Y.Crucial role of hematopoietic JAK2V617F mutation in the development of aortic aneurysms. 第4 回日本循環器学会基礎研究フォーラム; 20200926-27; Web.
Mimura K, Nakajima S, Kanke Y, Hanayama H, Watanabe Y, Hayase S, Okayama K, Saito M, Saze Z,Momma T, Kono K. The possibility of phosphor-STAT1 as a biomarker in anti-PD-1 antibody therapy forgastric cancer. 第58 回日本癌治療学会定期学術集会; 20201022-24; 京都/Web.
